IS:SUNPHARMA Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, such as psychiatry, anti-infectives, neurology, cardiology, orthopaedic, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental, and nutritionals. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances, as well as over-the-counter products. The company has a collaboration agreement with International Centre for Genetic Engineering and Biotechnology to develop Dengue vaccine. Sun Pharmaceutical Industries Limited was founded in 1983 and is based in Mumbai, India.

853.20 INR
As of 01/17/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  India
Country of incorporation:  India
IPO date:  12/31/1999
Stock exchange:    National Stock Exchange O
Exchange country:   India
Market cap:   2,062,823,981,056 INR
Current dividend yield:   0.87%
Sedol:      6582483

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy